Received Nov 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | UNK | EB9ZX | IM / LA |
Patient reported adverse event after administration of third dose of hepatitis b vaccine, indicating that she developed a body rash. Patient state that after several days the symptoms improved, but patient didn't visit primary care. We recommend a visit primary doctor to follow up .